• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care . Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypox

tetano

Editor, Senior Moderator
Crit Care


. 2024 Apr 23;28(1):134.
doi: 10.1186/s13054-024-04921-3. Case study observational research: inflammatory cytokines in the bronchial epithelial lining fluid of COVID-19 patients with acute hypoxemic respiratory failure

Kazuki Sudo[SUP] 1 2 [/SUP], Mao Kinoshita[SUP] 1 [/SUP], Ken Kawaguchi[SUP] 1 [/SUP], Kohsuke Kushimoto[SUP] 1 [/SUP], Ryogo Yoshii[SUP] 2 [/SUP], Keita Inoue[SUP] 2 [/SUP], Masaki Yamasaki[SUP] 2 3 [/SUP], Tasuku Matsuyama[SUP] 4 [/SUP], Kunihiko Kooguchi[SUP] 2 [/SUP], Yasuo Takashima[SUP] 5 [/SUP], Masami Tanaka[SUP] 5 [/SUP], Kazumichi Matsumoto[SUP] 6 [/SUP], Kei Tashiro[SUP] 5 [/SUP], Tohru Inaba[SUP] 6 7 [/SUP], Bon Ohta[SUP] 4 [/SUP], Teiji Sawa[SUP] 8 9 [/SUP]



Affiliations
Abstract

Background: In this study, the concentrations of inflammatory cytokines were measured in the bronchial epithelial lining fluid (ELF) and plasma in patients with acute hypoxemic respiratory failure (AHRF) secondary to severe coronavirus disease 2019 (COVID-19).
Methods: We comprehensively analyzed the concentrations of 25 cytokines in the ELF and plasma of 27 COVID-19 AHRF patients. ELF was collected using the bronchial microsampling method through an endotracheal tube just after patients were intubated for mechanical ventilation.
Results: Compared with those in healthy volunteers, the concentrations of interleukin (IL)-6 (median 27.6 pmol/L), IL-8 (1045.1 pmol/L), IL-17A (0.8 pmol/L), IL-25 (1.5 pmol/L), and IL-31 (42.3 pmol/L) were significantly greater in the ELF of COVID-19 patients than in that of volunteers. The concentrations of MCP-1 and MIP-1β were significantly greater in the plasma of COVID-19 patients than in that of volunteers. The ELF/plasma ratio of IL-8 was the highest among the 25 cytokines, with a median of 737, and the ELF/plasma ratio of IL-6 (median: 218), IL-1β (202), IL-31 (169), MCP-1 (81), MIP-1β (55), and TNF-α (47) were lower.
Conclusions: The ELF concentrations of IL-6, IL-8, IL-17A, IL-25, and IL-31 were significantly increased in COVID-19 patients. Although high levels of MIP-1 and MIP-1β were also detected in the blood samples collected simultaneously with the ELF samples, the results indicated that lung inflammation was highly compartmentalized. Our study demonstrated that a comprehensive analysis of cytokines in the ELF is a feasible approach for understanding lung inflammation and systemic interactions in patients with severe pneumonia.

Keywords: Bronchial microsampling; COVID-19; Cytokine; Epithelial lining fluid; Multiplex bead-based assay.

 
Back
Top Bottom